logo-loader
view4Imprint Group

4imprint’s orders slump 80% amid coronavirus disruption

The merchandising firm is scrapping the final dividend to save US$16mln

4Imprint Group - 4imprint’s orders slump 80% amid coronavirus disruption

4imprint Group PLC's (LON:FOUR) rose on Tuesday despite daily order counts slumping 80% from last year as restrictions to contain the coronavirus hit its markets.

The promotional merchandise firm has scrapped the final dividend of US$0.59 per share, saving US$16mln.

READ: 4imprint warns on profits as orders plummet

At the end of March, cash in the bank was US$50mln.

The FTSE 250-listed company said that marketing, the second-largest expense after products, has been “radically re-shaped” but maintained to take  “full advantage” if business starts to recover.

Analysts at house broker Peel Hunt said 4imprint is expected to break even or make "a small profit" this year.

Shares inched up 1% to 1,846.48p on Tuesday morning.

--Adds analyst's comment, shares--

Quick facts: 4Imprint Group

Price: - -

AQSE:FOUR
Market: AQSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

CytoDyn continues to works on licensing deals as FDA continues its review on...

CytoDyn (OTCQB: CYDY) President and Chief Executive Officer Nader Pourhassan joined Steve Darling from Proactive to discuss a number of issues including the very latest on their clinical trials for a COVID-19 treatment. Pourhassan also told Proactive that they are in discussions with numerous...

30 minutes ago

2 min read